정맥 내 수액 요법 시장 규모 조사: 서비스, 구성요소, 최종 사용자 및 지역별 예측(2022-2032년)

Global Intravenous (IV) hydration therapy Market is valued at approximately USD 2.51 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.21% over the forecast period 2024-2032. The Global Intravenous (IV) Hydration Therapy Market involves the administration of fluids directly into the bloodstream to treat dehydration and deliver essential nutrients. Several important trends have led to significant growth in the market. The rising prevalence of chronic diseases such as diabetes and cancer has increased the demand for IV hydration therapy, especially in hospital settings. The growing popularity of wellness and preventive healthcare has led to an increase in outpatient clinics and mobile IV therapy services, driving market expansion. Additionally, the ageing population globally has fueled the demand for IV hydration therapy among elderly patients who have difficulty consuming fluids orally. Advancements in technology, such as smart pumps and integrated monitoring systems, are enhancing the safety and efficiency of IV therapy, further boosting market growth. These trends are driving attention and investment in the Global Intravenous (IV) Hydration Therapy Market.

The Global Intravenous (IV) Hydration Therapy Market is driven by diverse factors. The increasing prevalence of chronic diseases worldwide drives a higher demand for IV therapy in clinical settings, especially for patients with complex conditions. IV hydration therapy's expanding adoption in sports medicine and wellness also boosts market growth. Technological advances in IV equipment enhance safety and efficacy, further fueling market expansion. However, alongside these drivers, the market faces certain restraints. One key restraint is the potential risks associated with IV therapy, including infection, fluid overload, and vein irritation. These risks necessitate stringent protocols and skilled healthcare professionals to ensure safe and effective treatment. Balancing the benefits of IV hydration therapy with these inherent risks remains a critical challenge for healthcare providers and industry stakeholders, influencing market dynamics and adoption rates.

The key regions considered for the Global Intravenous (IV) hydration therapy market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America stands out as a dominating region due to its well-established healthcare infrastructure, advanced medical technologies, and high adoption rates of IV therapy for various medical conditions. The region's robust reimbursement policies and strong presence of key market players further contribute to its leadership position in the IV Hydration Therapy Market. The region boasts high patient spending and high disposable income on overall wellness, which increases the adoption of the market. Furthermore, major stakeholders in the area are consistently placing their attention on implementing modern technologies in the market to accommodate evolving consumer needs, a factor that is expected to boost market expansion. The market in Asia Pacific, on the other hand, is expected to develop at the fastest rate over the forecast period.

Major market player included in this report are:

• Core IV Therapy, LLC
• Cryojuvenate UK Ltd.
• B. Braun Medical Inc.
• Otsuka Pharmaceutical Co., Ltd.
• NexGen Health
• JW Life Science Corporation
• Amanta Healthcare Ltd.
• Baxter International Inc.
• Drip Hydration
• Smiths Medical, Inc.

The detailed segments and sub-segment of the market are explained below:

By Service

• Immune Boosters
• Energy Boosters
• Skin Care
• Migraine
• Other

By Component

• Medicated
• Non-medicated

By End User

• Hospitals & Clinics
• Wellness centres and spas
• Home Healthcare
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1.Global Intravenous (IV) Hydration Therapy Market Definition and Research Assumptions

• 1.1.Research Objective
• 1.2.Market Definition
• 1.3.Research Assumptions
  • 1.3.1.Inclusion & Exclusion
  • 1.3.2.Limitations
  • 1.3.3.Supply Side Analysis
    • 1.3.3.1.Availability
    • 1.3.3.2.Infrastructure
    • 1.3.3.3.Regulatory Environment
    • 1.3.3.4.Market Competition
    • 1.3.3.5.Economic Viability (Consumer's Perspective)
  • 1.3.4.Demand Side Analysis
    • 1.3.4.1.Regulatory frameworks
    • 1.3.4.2.Technological Advancements
    • 1.3.4.3.Environmental Considerations
    • 1.3.4.4.Consumer Awareness & Acceptance
• 1.4.Estimation Methodology
• 1.5.Years Considered for the Study
• 1.6.Currency Conversion Rates

Chapter 2.Executive Summary

• 2.1.Global Intravenous (IV) Hydration Therapy Market Size & Forecast (2022- 2032)
• 2.2.Regional Summary
• 2.3.Segmental Summary
  • 2.3.1.By Service
  • 2.3.2.By Component
  • 2.3.3.By End User
• 2.4.Key Trends
• 2.5.Recession Impact
• 2.6.Analyst Recommendation & Conclusion

Chapter 3.Global Intravenous (IV) Hydration Therapy Market Dynamics

• 3.1.Market Drivers
• 3.2.Market Challenges
• 3.3.Market Opportunities

Chapter 4.Global Intravenous (IV) Hydration Therapy Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
  • 4.1.6.Futuristic Approach to Porter's 5 Force Model
  • 4.1.7.Porter's 5 Force Impact Analysis
• 4.2.PESTEL Analysis
  • 4.2.1.Political
  • 4.2.2.Economical
  • 4.2.3.Social
  • 4.2.4.Technological
  • 4.2.5.Environmental
  • 4.2.6.Legal
• 4.3.Top investment opportunity
• 4.4.Top winning strategies
• 4.5.Disruptive Trends
• 4.6.Industry Expert Perspective
• 4.7.Analyst Recommendation & Conclusion

Chapter 5.Global Intravenous (IV) Hydration Therapy Market Size & Forecasts by Service 2022-2032

• 5.1.Immune Boosters
• 5.2.Energy Boosters
• 5.3.Skin Care
• 5.4.Migraine
• 5.5.Other

Chapter 6.Global Intravenous (IV) Hydration Therapy Market Size & Forecasts by Component 2022-2032

• 6.1. Medicated
• 6.2.Non-medicated

Chapter 7.Global Intravenous (IV) Hydration Therapy Market Size & Forecasts by End User 2022-2032

• 7.1. Hospitals & Clinics
• 7.2.Wellness centres and spas
• 7.3.Home Healthcare
• 7.4.Others

Chapter 8.Global Intravenous (IV) Hydration Therapy Market Size & Forecasts by Region 2022-2032

• 8.1.North America Intravenous (IV) Hydration Therapy Market
  • 8.1.1.U.S. Intravenous (IV) Hydration Therapy Market
    • 8.1.1.1. Service breakdown size & forecasts, 2022-2032
    • 8.1.1.2.Component breakdown size & forecasts, 2022-2032
    • 8.1.1.3.End User breakdown size & forecasts, 2022-2032
  • 8.1.2.Canada Intravenous (IV) Hydration Therapy Market
• 8.2.Europe Intravenous (IV) Hydration Therapy Market
  • 8.2.1.U.K. Intravenous (IV) Hydration Therapy Market
  • 8.2.2.Germany Intravenous (IV) Hydration Therapy Market
  • 8.2.3.France Intravenous (IV) Hydration Therapy Market
  • 8.2.4.Spain Intravenous (IV) Hydration Therapy Market
  • 8.2.5.Italy Intravenous (IV) Hydration Therapy Market
  • 8.2.6.Rest of Europe Intravenous (IV) Hydration Therapy Market
• 8.3.Asia-Pacific Intravenous (IV) Hydration Therapy Market
  • 8.3.1.China Intravenous (IV) Hydration Therapy Market
  • 8.3.2.India Intravenous (IV) Hydration Therapy Market
  • 8.3.3.Japan Intravenous (IV) Hydration Therapy Market
  • 8.3.4.Australia Intravenous (IV) Hydration Therapy Market
  • 8.3.5.South Korea Intravenous (IV) Hydration Therapy Market
  • 8.3.6.Rest of Asia Pacific Intravenous (IV) Hydration Therapy Market
• 8.4.Latin America Intravenous (IV) Hydration Therapy Market
  • 8.4.1.Brazil Intravenous (IV) Hydration Therapy Market
  • 8.4.2.Mexico Intravenous (IV) Hydration Therapy Market
  • 8.4.3.Rest of Latin America Intravenous (IV) Hydration Therapy Market
• 8.5.Middle East & Africa Intravenous (IV) Hydration Therapy Market
  • 8.5.1. Saudi Arabia Intravenous (IV) Hydration Therapy Market
  • 8.5.2. South Africa Intravenous (IV) Hydration Therapy Market
  • 8.5.3.Rest of Middle East & Africa Intravenous (IV) Hydration Therapy Market

Chapter 9.Competitive Intelligence

• 9.1.Key Company SWOT Analysis
• 9.2.Top Market Strategies
• 9.3.Company Profiles
  • 9.3.1. Core IV Therapy, LLC
    • 9.3.1.1.Key Information
    • 9.3.1.2.Overview
    • 9.3.1.3.Financial (Subject to Data Availability)
    • 9.3.1.4.Product Summary
    • 9.3.1.5.Market Strategies
  • 9.3.2. Cryojuvenate UK Ltd.
  • 9.3.3.B. Braun Medical Inc.
  • 9.3.4.Otsuka Pharmaceutical Co., Ltd.
  • 9.3.5.NexGen Health
  • 9.3.6.JW Life Science Corporation
  • 9.3.7.Amanta Healthcare
  • 9.3.8.Baxter International Inc.
  • 9.3.9. Smiths Medical, Inc.
  • 9.3.10. Drip Hydration

Chapter 10.Research Process

• 10.1.Research Process
  • 10.1.1.Data Mining
  • 10.1.2.Analysis
  • 10.1.3.Market Estimation
  • 10.1.4.Validation
  • 10.1.5.Publishing
• 10.2.Research Attributes